| 臺大學術典藏 |
2018-09-10T05:45:46Z |
Emergency department presentation of chronic peritoneal dialysis patients
|
Pai, M.-F.;Hsu, S.-P.;Peng, Y.-S.;Chiang, C.-K.;Ho, T.-I.;Shao, Y.Y.;Lee, H.-Y.;Hung, K.-Y.; CHIH-KANG CHIANG |
| 臺大學術典藏 |
2017 |
Hepatitis C virus core protein potentiates proangiogenic activity of hepatocellular carcinoma cells
|
Shao Y.-Y.;Min-Shu Hsieh;Wang H.-Y.;Li Y.-S.;Lin H.;Hsu H.-W.;Huang C.-Y.;Hsu C.-H.;Cheng A.-L.; Shao Y.-Y.; MIN-SHU HSIEH; Wang H.-Y.; Li Y.-S.; Lin H.; Hsu H.-W.; Huang C.-Y.; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2017 |
Hepatitis C virus core protein potentiates proangiogenic activity of hepatocellular carcinoma cells
|
Lin H.; Shao Y.-Y.;Hsieh M.-S.;Wang H.-Y.;Li Y.-S.;Lin H.;Hsu H.-W.;Huang C.-Y.;Chih-Hung Hsu;Cheng A.-L.; Shao Y.-Y.; Hsieh M.-S.; Wang H.-Y.; Li Y.-S.; Hsu H.-W.; Huang C.-Y.; CHIH-HUNG HSU; Cheng A.-L. |
| 臺大學術典藏 |
2017 |
Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)
|
Di Laurenzio L.; Lee R.; Larson S.M.; Cheng A.-L.; Carrasquilo J.A.; Ohishi N.; Chen Y.-C.; Agajanov T.; Boisserie F.; Morikawa H.; Maki Y.; Tanaka T.; Ohtomo T.; Schwartz L.; Smith-Jones P.M.; Frenette C.; O’Neil B.; Shao Y.-Y.; Wan P.; Ma J.; Gansukh B.; Lyashchenko S.K.; Pandit-Taskar N.; Ruan S.; Beylergil V.; O’Donoghue J.; Yen C.-J.; CHIH-HUNG HSU; Abou-Alfa G.K.; Abou-Alfa G.K.;Yen C.-J.;Chih-Hung Hsu;O’Donoghue J.;Beylergil V.;Ruan S.;Pandit-Taskar N.;Gansukh B.;Lyashchenko S.K.;Ma J.;Wan P.;Shao Y.-Y.;Lin Z.-Z.;Frenette C.;O’Neil B.;Schwartz L.;Smith-Jones P.M.;Ohtomo T.;Tanaka T.;Morikawa H.;Maki Y.;Ohishi N.;Chen Y.-C.;Agajanov T.;Boisserie F.;Di Laurenzio L.;Lee R.;Larson S.M.;Cheng A.-L.;Carrasquilo J.A.; Lin Z.-Z. |
| 臺大學術典藏 |
2017 |
Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy
|
Shao Y.-Y.;Bang-Bin Chen;Ou D.-L.;Lin Z.-Z.;Hsu C.-H.;Wang M.-J.;Cheng A.-L.;Hsu C.; Shao Y.-Y.; BANG-BIN CHEN; Ou D.-L.; Lin Z.-Z.; Hsu C.-H.; Wang M.-J.; Cheng A.-L.; Hsu C. |
| 臺大學術典藏 |
2017 |
Right or left? Side selection for a totally implantable vascular access device: A randomised observational study
|
Hsu C.-H; Lin C.-P; WEN-YING LIN; Lee Y.-H; Lin Y.-T; Hsu M.-C; Shao Y.-Y. |
| 國立成功大學 |
2017 |
Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)
|
Abou-Alfa, G.K.;Yen, C.-J.;Hsu, C.-H.;O’Donoghue, J.;Beylergil, V.;Ruan, S.;Pandit-Taskar, N.;Gansukh, B.;Lyashchenko, S.K.;Ma, J.;Wan, P.;Shao, Y.-Y.;Lin, Z.-Z.;Frenette, C.;O’Neil, B.;Schwartz, L.;Smith-Jones, P.M.;Ohtomo, T.;Tanaka, Tanaka T.;Morikawa, H.;Maki, Y.;Ohishi, N.;Chen, Y.-C.;Agajanov, T.;Boisserie, F.;Di, Laurenzio L.;Lee, R.;Larson, S.M.;Cheng, A.-L.;Carrasquilo, J.A. |
| 國立成功大學 |
2017 |
Impact of Undertreatment of Cancer Pain With Analgesic Drugs on Patient Outcomes: A Nationwide Survey of Outpatient Cancer Patient Care in Taiwan
|
Shen, W.-C.;Chen, J.-S.;Shao, Y.-Y.;Lee, K.-D.;Chiou, T.-J.;Sung, Y.-C.;Rau, K.-M.;Yen, C.-J.;Liao, Y.-M.;Liu, T.-C.;Wu, M.-F.;Lee, M.-Y.;Yu, M.-S.;Hwang, W.-L.;Lai, P.-Y.;Chang, Chang C.-S.;Chou, W.-C.;Hsieh, R.-K. |
| 國立臺灣大學 |
2016 |
Lenalidomide as second-line therapy for advanced hepatocellular carcinoma (HCC): biomarker exploration
|
Shao, Y-Y.; Chen, B-B.; Lin, Z-Z.; Hsu, C-H.; Wang, M-J.; Cheng, A-L.; Hsu, C.; 邵幼雲; 林宗哲; 鄭安理; 陳邦斌; 徐志宏; 許駿 |
| 國立成功大學 |
2015-12-01 |
A clinical survey on satisfaction of pain management in hospitalized patients with cancer in Taiwan
|
Lin, J.; Chang, C. -S.; Lee, M. -Y.; Liao, Y. -M.; Wu, M. -F.; Sung, Y. -C.; Rau, K. -M.; Yu, M. -S.; Lai, P. -Y.; Chiou, T. -J.; Chen, J. -S.; Lee, K. -D.; Hwang, W. -L.; Liu, T. -C.; Yen, C. -J.; Shao, Y. -Y.; Hsieh, R. -K. |
| 國立成功大學 |
2015-12-01 |
Impact and predictive factor of undertreatment of analgesic drug in outpatients with cancer: a nationwide of clinical pain survey in Taiwan
|
Yang, C. -K.; Chou, W. -C.; Shen, W. -C.; Chen, J. -S.; Lee, K. -D.; Yen, C. -J.; Lai, P. -Y.; Shao, Y. -Y.; Hwang, W. -L.; Chiou, T. -J.; Sung, Y. -C.; Rau, K. -M.; Liao, Y. -M.; Chang, C. S.; Wu, M. -F.; Lee, M. -Y.; Yu, M. -S.; Liu, T. -C.; Hsieh, R. -K. |
| 臺大學術典藏 |
2015 |
The prognostic impact of type 2 diabetes mellitus on early cervical cancer in Asia
|
Kuo H.-Y.;Lin Z.-Z.;Kuo R.;Shau W.-Y.;Lai C.-L.;Yang Y.-Y.;Shao Y.-Y.;Hsu C.;Wen-Fang Cheng;Cheng A.-L.;Yang J.C.H.;Lai M.-S.; Kuo H.-Y.; Lin Z.-Z.; Kuo R.; Shau W.-Y.; Lai C.-L.; Yang Y.-Y.; Shao Y.-Y.; Hsu C.; WEN-FANG CHENG; Cheng A.-L.; Yang J.C.H.; Lai M.-S. |
| 臺大學術典藏 |
2015 |
Predictive biomarkers of sorafenib efficacy in advanced hepatocellular carcinoma: Are we getting there?
|
Shao Y.-Y.; CHIH-HUNG HSU; Cheng A.-L.; Shao Y.-Y.;Chih-Hung Hsu;Cheng A.-L. |
| 臺大學術典藏 |
2015 |
Statin Use Is Associated With Improved Prognosis of Colorectal Cancer in Taiwan
|
Lai C.-L.; Lin Z.-Z.; Cheng A.-L.; Lai M.-S.; Yeh Y.-C.; Chen H.-M.; Yeh K.-H.; Shao Y.-Y.; CHIH-HUNG HSU; Shao Y.-Y.;Chih-Hung Hsu;Yeh K.-H.;Chen H.-M.;Yeh Y.-C.;Lai C.-L.;Lin Z.-Z.;Cheng A.-L.;Lai M.-S. |
| 臺大學術典藏 |
2015 |
High serum transforming growth factor-β1 levels predict outcome in hepatocellular carcinoma patients treated with sorafenib
|
Lin T.-H.;Shao Y.-Y.;Chan S.-Y.;Huang C.-Y.;Chih-Hung Hsu;Cheng A.-L.; Lin T.-H.; Shao Y.-Y.; Chan S.-Y.; Huang C.-Y.; CHIH-HUNG HSU; Cheng A.-L. |
| 臺大學術典藏 |
2015 |
Treatment efficacy differences of sorafenib for advanced hepatocellular carcinoma: A meta-analysis of randomized clinical trials
|
Shao Y.-Y.;Shau W.-Y.;Chan S.-Y.;Lu L.-C.;Chih-Hung Hsu;Cheng A.-L.; Shao Y.-Y.; Shau W.-Y.; Chan S.-Y.; Lu L.-C.; CHIH-HUNG HSU; Cheng A.-L. |
| 臺大學術典藏 |
2014 |
β-Catenin (CTNNB1) mutations are not associated with prognosis in advanced hepatocellular carcinoma
|
Shao Y.-Y.; Lee Y.-H.; Hsieh M.-S.; Hsiao C.-H.; Lin H.-H.; Kao H.-F.; Ma Y.-Y.; Yen F.-C.; Cheng A.-L.; CHIH-HUNG HSU; Lu L.-C.; Lu L.-C.;Shao Y.-Y.;Lee Y.-H.;Hsieh M.-S.;Hsiao C.-H.;Lin H.-H.;Kao H.-F.;Ma Y.-Y.;Yen F.-C.;Cheng A.-L.;Chih-Hung Hsu |
| 臺大學術典藏 |
2013 |
A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapy
|
Shao Y.-Y.; Liang P.-C.; Wu Y.-M.; Huang C.-C.; Huang K.-W.; Cheng J.C.; Hsu C.-H.; CHIUN HSU; Cheng A.-L.; Lin Z.-Z. |
| 臺大學術典藏 |
2013 |
Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II study
|
Hsu C.-H.; Kang Y.K.; Yang T.-S.; Shun C.-T.; Shao Y.-Y.; Su W.-C.; Sandoval-Tan J.; Chiou T.-J.; Jin K.; CHIUN HSU; Cheng A.-L. |
| 實踐大學 |
2012 |
Protective effect of antrosterol from Antrodia camphorata submerged whole broth against carbon tetrachloride-induced acute liver injury in mice
|
Huang, G.J.;Deng, J.S.;Huang, S.S.;Shao, Y.Y.;Chen, C.C.;Kuo, Y.H. |
| 國立臺灣大學 |
2012 |
HOSPITAL VOLUMES OF PERCUTANEOUS RADIOFREQUENCY ABLATION ASSOCIATED WITH ITS TREATMENT OUTCOMES FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA
|
Shao, Y. -Y.; Lu, L. -C.; Kuo, R. N. C.; Lin, Z. -Z.; Yeh, Y. -C.; Shau, W. -Y.; Hsu, C. -H.; Cheng, A. -L.; Lai, M. -S.; 邵幼雲; 林宗哲; 鄭安理; 徐志宏; 呂理駿 |
| 國立臺灣大學 |
2012 |
Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems
|
Shao, Y-Y; Lu, L-C; Lin, Z-Z; Hsu, C.; Shen, Y-C; Hsu, C-H; Cheng, A-L; 邵幼雲; 林宗哲; 鄭安理; 徐志宏; 許駿; 呂理駿 |
| 國立臺灣大學 |
2012 |
LOW FREQUENCIES OF BRAF AND B-CATENIN (CTNNB1) MUTATIONS IN ADVANCED HEPATOCELLULAR CARCINOMA
|
Lu, L. -C.; Shao, Y. -Y.; Hsieh, M. -S.; Huang, C. -C.; Cheng, A. -L.; Hsu, C. -H.; 邵幼雲; 鄭安理; 徐志宏; 呂理駿; 謝明書 |
| 臺大學術典藏 |
2012 |
Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma
|
Shau W.-Y.; Shao Y.-Y.; Yeh Y.-C.; Lin Z.-Z.; Kuo R.; Hsu C.-H.; Chiun Hsu; Cheng A.-L.; Lai M.-S. |
| 臺大學術典藏 |
2012 |
Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer
|
Lu L.-C.; Shao Y.-Y.; Hsu C.-H.; CHIUN HSU; Cheng W.-F.; Lin Y.-L.; Cheng A.-L.; Yeh K.-H. |
